Tentarix Biotherapeutics
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $35M
Overview
A biotech pioneering conditionally active, multifunctional 'Tentacle' biologics for targeted cancer and autoimmune disease treatment.
OncologyImmunology
Technology Platform
A platform for designing 'Tentacle' biologics—multifunctional, conditionally active proteins that engage targets specifically in the disease microenvironment.
Funding History
1Total raised:$35M
Series B$35M
Opportunities
Its platform could unlock new targets and combinations previously limited by toxicity, creating high-value, differentiated therapeutics.
Risk Factors
The novel and complex biology of its molecules carries significant development and manufacturing risks.
Competitive Landscape
Operates in the competitive bispecific and tumor-targeting antibody space but aims to differentiate through its unique conditional activity mechanism.